|
Restenosis
Citations 91-100 of 538 total displayed.
|
Past content
(since Jan 1999):
|
- Editorials
Cardiology Is Flow
- Yoram Richter and Elazer R. Edelman
Circulation 2006;113:2679-2682, doi:10.1161/CIRCULATIONAHA.106.632687
[Full text]
- Articles
Reduced Connexin43 Expression Limits Neointima Formation After Balloon Distension Injury in Hypercholesterolemic Mice
- Christos E. Chadjichristos, Christian M. Matter, Isabelle Roth, Esther Sutter, Graziano Pelli, Thomas F. Lüscher, Marc Chanson, and Brenda R. Kwak
Circulation published June 12, 2006, doi:10.1161/CIRCULATIONAHA.106.627703
[Abstract]
- Articles
Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement. Results From the PREMIER Registry
- John A. Spertus, Richard Kettelkamp, Clifton Vance, Carole Decker, Philip G. Jones, John S. Rumsfeld, John C. Messenger, Sanjaya Khanal, Eric D. Peterson, Richard G. Bach, Harlan M. Krumholz, and David J. Cohen
Circulation published June 12, 2006, doi:10.1161/CIRCULATIONAHA.106.618066
[Abstract]
- Editorials
Pushing Drug-Eluting Stents Into Uncharted Territory: Simpler Than You Think—More Complex Than You Imagine
- Campbell Rogers and Elazer R. Edelman
Circulation 2006;113:2262-2265, doi:10.1161/CIRCULATIONAHA.106.623470
[Full text]
- Interventional Cardiology
Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents
- Adnan Kastrati, Alban Dibra, Julinda Mehilli, Sandra Mayer, Susanne Pinieck, Jürgen Pache, Josef Dirschinger, and Albert Schömig
Circulation 2006;113:2293-2300; published online before print as doi:10.1161/CIRCULATIONAHA.105.601823
[Abstract]
[Full text]
- Articles
Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents
- Adnan Kastrati, Alban Dibra, Julinda Mehilli, Sandra Mayer, Susanne Pinieck, Jürgen Pache, Josef Dirschinger, and Albert Schömig
Circulation published May 8, 2006, doi:10.1161/CIRCULATIONAHA.105.601823
[Abstract]
- Interventional Cardiology
Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss
- Julinda Mehilli, Adnan Kastrati, Rainer Wessely, Alban Dibra, Jörg Hausleiter, Birgit Jaschke, Josef Dirschinger, Albert Schömig for the Intracoronary Stenting and Angiographic Restenosis–Test Equivalence Between 2 Drug-Eluting Stents (ISAR-TEST) Trial Investigators
Circulation 2006;113:273-279; published online before print as doi:10.1161/CIRCULATIONAHA.105.575977
[Abstract]
[Full text]
- Articles
Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss
- Julinda Mehilli, Adnan Kastrati, Rainer Wessely, Alban Dibra, Jörg Hausleiter, Birgit Jaschke, Josef Dirschinger, Albert Schömig for the Intracoronary Stenting and Angiographic Restenosis-Test Equivalence Between 2 Drug-Eluting Stents (ISAR-TEST) Trial Investigators
Circulation published January 3, 2006, doi:10.1161/CIRCULATIONAHA.105.575977
[Abstract]
- Correspondence
Letter Regarding Article by Mauri et al, "Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison" • Response
- Pierfrancesco Agostoni, Laura Mauri, E. John Orav, and Richard E. Kuntz
Circulation 2005;112:e358, doi:10.1161/CIRCULATIONAHA.105.574954
[Full text]
- Images in Cardiovascular Medicine
Optical Coherence Tomography Findings at 5-Year Follow-Up After Coronary Stent Implantation
- E. Regar, H.M.M. van Beusekom, W.J. van der Giessen, and P.W. Serruys
Circulation 2005;112:e345-346e, doi:10.1161/CIRCULATIONAHA.104.531897
[Full text]
|
|
